The Global Intravascular Ultrasound [IVUS] Devices Market is projected to reach $728.57 million by 2028, from a value of $429.67 million in 2022, by registering a CAGR of 9.2% during the forecast period. The technological advancements, inclination towards less invasive procedures, increase in the image output quality and developments in the image-guided therapeutic treatment are driving the market growth. However, high costs and lack of uniform reimbursement are hampering the growth of the market. Moreover, increasing incidence of cardiovascular diseases is boosting the market growth.
Recent Developments
In September 2021, Siemens Healthineers introduced Luminos Impulse, a fluoroscopy system with a novel design and characteristics shared by high-end fluoroscopy systems inclusive of a smooth imaging chain, exhaustive dose optimization, cybersecurity characteristics, and detector-sharing possibilities for radiography.
In May 2021, Siemens Healthineers introduced Somatom X.ceed, a novel high-resolution, high-speed CT (computed tomography) scanner engineered particularly for the most demanding clinical areas where time and accuracy are of significance.
In January 2021, Avinger, Inc. declared complete commercial kick-off of its Tigereye™ image-guided chronic total occlusion (CTO) crossing system. With the introduction of complete commercial kick-off, current and prospective accounts all through the U.S. and Germany are presently capable of placing orders for the Tigereye appliance. At the time of the final quarter of 2020, Avinger administered a restricted kick-off at 12 clinical centers in the U.S. and Germany
In July 2018, Conavi Medical was granted with the U.S. FDA clearance for its Novasight hybrid imaging system, which allows simultaneous imaging of coronary arteries with both intravascular ultrasound system and optical coherence tomography. IVUS or OCT are used by interventional cardiologists to image coronary anatomy during angioplasty and stenting procedures.
Competitive Landscape
Allergan plc, AstraZeneca, Bayer HealthCare Pharmaceuticals, Biogen, Inc., GlaxoSmithKline Plc, H. Lundbeck A/S, Johnson & Johnson, Novartis AG, Parion Sciences, Inc., Pfizer Inc and Sanofi S.A. are some of the major players in the global Intravascular Ultrasound [IVUS] Devices market.